Cargando…
‘End-stage’ heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation
The final therapy of ‘end-stage heart failure’ is orthotopic heart, lung or heart-lung transplantation. However, these options are not available for many patients worldwide. Therefore, novel therapeutical strategies are needed. Based on pathophysiological insights regarding (1) the long-term impact...
Autores principales: | Schranz, Dietmar, Akintuerk, Hakan, Voelkel, Norbert F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293839/ https://www.ncbi.nlm.nih.gov/pubmed/28011759 http://dx.doi.org/10.1136/heartjnl-2015-309110 |
Ejemplares similares
-
Hypoplastic Left Heart: Stage-I Will be Performed Interventionally, Soon
por: Schranz, Dietmar, et al.
Publicado: (2021) -
Hypoplastic Left Heart Stage I: No Norwood, No Hybrid
por: Schranz, Dietmar, et al.
Publicado: (2020) -
“Nihilism” of chronic heart failure therapy in children and why effective therapy is withheld
por: Schranz, Dietmar, et al.
Publicado: (2016) -
Creation of a restrictive atrial communication in pulmonary arterial hypertension (PAH): effective palliation of syncope and end-stage heart failure
por: Bauer, Anna, et al.
Publicado: (2018) -
Cardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart
por: Mienert, Tino, et al.
Publicado: (2021)